In contrast to paired adjacent normal colorectal mucosa, levels of COX-2 mRNA are found to be overexpressed in over 80% of colorectal tumors, suggesting a function for COX-2 as a potential biomarker for cancer risk. COX-2 inhibitors may be useful in the chemoprevention of colon cancer. Here, PTGS2 is linked to colonic neoplasm.